|
⚲
|
| Keyboard |
| Deerfield Mgmt V LP | |
|---|---|
| Firm | Deerfield Management Company LP |
| Address | 780 Third Avenue, 37th Floor New York, NY 10017 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Deerfield Management Company LP | |||||
| Deerfield Private Design Fund V LP | 021-372234 | Executive Officer | of 2,500.0 M |
1,340.5 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
BiomX Inc PHGE
Warrants · derivative
|
2025-04-21 | Grant | 1,611,864 | ||
|
BiomX Inc PHGE
Warrants · derivative
|
2025-04-21 | Grant | 1,611,864 | ||
|
BiomX Inc PHGE
Warrants · derivative
|
2025-02-27 | Grant | 1,258,614 | ||
|
BiomX Inc PHGE
Warrants · derivative
|
2025-02-27 | Option exercise | 1,611,863 | ||
|
BiomX Inc PHGE
Warrants · derivative
|
2025-02-27 | Option exercise | 1,611,863 | ||
|
BiomX Inc PHGE
Common Stock
|
2025-02-27 | Option exercise | 353,249 | $0.93 | 328,522 |
|
BiomX Inc PHGE
Common Stock
|
2025-02-27 | Option exercise | 353,249 | $0.93 | 328,522 |
|
BiomX Inc PHGE
Warrants · derivative
|
2025-02-27 | Grant | 1,258,614 | ||
|
Bicara Therapeutics Inc BCAX
Series C Preferred Stock · derivative
|
2024-09-17 | Conversion | 7,973,325 | ||
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2024-09-17 | Buy | 35,000 | $18.00 | 630,000 |
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2024-09-17 | Buy | 35,000 | $18.00 | 630,000 |
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2024-09-17 | Conversion | 862,587 | ||
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2024-09-17 | Conversion | 862,587 | ||
|
Bicara Therapeutics Inc BCAX
Series C Preferred Stock · derivative
|
2024-09-17 | Conversion | 7,973,325 | ||
|
BiomX Inc PHGE
Common Stock
|
2024-07-15 | Option exercise | 5,883,000 | ||
|
BiomX Inc PHGE
Series X Non-Voting Convertible Preferred Stock · derivative
|
2024-07-15 | Option exercise | 5,883 | ||
|
BiomX Inc PHGE
Common Stock
|
2024-07-15 | Option exercise | 5,883,000 | ||
|
BiomX Inc PHGE
Series X Non-Voting Convertible Preferred Stock · derivative
|
2024-07-15 | Option exercise | 5,883 | ||
|
BiomX Inc PHGE
Warrants · derivative
|
2024-07-09 | Grant | 20,175,000 | ||
|
BiomX Inc PHGE
Warrants · derivative
|
2024-07-09 | Grant | 722,175 | ||
| showing 20 of 40 most recent transactions | |||||